Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

Some countries limit AstraZeneca vaccine use, EU findings on J&J shot expected

Some countries limit AstraZeneca vaccine use, EU findings on J&J shot expected

SOME countries are restricting use of the AstraZeneca COVID-19 vaccine to certain age groups, or suspending use, after European and British regulators confirmed possible links to rare blood clots. Johnson & Johnson's vaccine has also been hit by concerns over blood clots. European regulators will issue findings later of their review into clotting issues in adults who had received the shot in the United States. U.S. health agencies recommended pausing the single shot's use temporarily on April 13 after reports of six cases in women under 50. A health advisory panel will meet on April 23 to discuss whether the…
Read More
SA sells vaccines to other African countries

SA sells vaccines to other African countries

SOUTH Africa has concluded the sale of AstraZeneca COVID-19 vaccines it had acquired but did not use to other African Union (AU) member states, the health ministry has announced. The country had paused AstraZeneca vaccinations last month because of a small trial showing the shot offered minimal protection against mild to moderate illness caused by the dominant local coronavirus variant. At the time, South Africa had received 1 million AstraZeneca doses from the Serum Institute of India and the delivery of another 500,000 was pending. The ministry said it had in the past weeks worked to ensure that all member…
Read More